Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

808 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ENTIMOS: A Discrete Event Simulation Model for Maximising Efficiency of Infusion Suites in Centres Treating Multiple Sclerosis Patients.
Lacinova K, Thokala P, Nicholas R, Dobay P, Scalfaro E, Angehrn Z, Brennan R, Boer I, Lines C, Adlard N. Lacinova K, et al. Among authors: brennan r. Appl Health Econ Health Policy. 2022 Sep;20(5):731-742. doi: 10.1007/s40258-022-00733-0. Epub 2022 May 19. Appl Health Econ Health Policy. 2022. PMID: 35585305 Free PMC article.
Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis.
Samjoo IA, Klotz L, Giovannoni G, Drudge C, Haltner A, Worthington E, Zhao M, Brennan R, Häring DA, Cameron C, Adlard N. Samjoo IA, et al. Among authors: brennan r. Mult Scler Relat Disord. 2022 Oct;66:104031. doi: 10.1016/j.msard.2022.104031. Epub 2022 Jul 4. Mult Scler Relat Disord. 2022. PMID: 35841716
Individual Differences in the Patient Experience of Relapsing Multiple Sclerosis (RMS): A Multi-Country Qualitative Exploration of Drivers of Treatment Preferences Among People Living with RMS.
Tatlock S, Sully K, Batish A, Finbow C, Neill W, Lines C, Brennan R, Adlard N, Backhouse T. Tatlock S, et al. Among authors: brennan r. Patient. 2023 Jul;16(4):345-357. doi: 10.1007/s40271-023-00617-y. Epub 2023 Apr 5. Patient. 2023. PMID: 37017920 Free PMC article.
Does the Multiple Sclerosis Impact Scale-29 (MSIS-29) have the range to capture the experience of fully ambulatory multiple sclerosis patients? Learnings from the ASCLEPIOS studies.
Regnault A, Loubert A, Brennan R, Meunier J, Naujoks C, Cano S, Adlard N. Regnault A, et al. Among authors: brennan r. Mult Scler J Exp Transl Clin. 2023 Sep 28;9(3):20552173231201422. doi: 10.1177/20552173231201422. eCollection 2023 Jul-Sep. Mult Scler J Exp Transl Clin. 2023. PMID: 37780483 Free PMC article.
Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer.
van Kalsbeek RJ, Hudson MM, Mulder RL, Ehrhardt M, Green DM, Mulrooney DA, Hakkert J, den Hartogh J, Nijenhuis A, van Santen HM, Schouten-van Meeteren AYN, van Tinteren H, Verbruggen LC, Conklin HM, Jacola LM, Webster RT, Partanen M, Kollen WJW, Grootenhuis MA, Pieters R, Kremer LCM; International Childhood Cancer Outcome Project participants. van Kalsbeek RJ, et al. Nat Med. 2024 May 22. doi: 10.1038/s41591-024-03065-9. Online ahead of print. Nat Med. 2024. PMID: 38778213 No abstract available.
The state of the art in secondary pharmacology and its impact on the safety of new medicines.
Brennan RJ, Jenkinson S, Brown A, Delaunois A, Dumotier B, Pannirselvam M, Rao M, Ribeiro LR, Schmidt F, Sibony A, Timsit Y, Sales VT, Armstrong D, Lagrutta A, Mittlestadt SW, Naven R, Peri R, Roberts S, Vergis JM, Valentin JP. Brennan RJ, et al. Nat Rev Drug Discov. 2024 May 21. doi: 10.1038/s41573-024-00942-3. Online ahead of print. Nat Rev Drug Discov. 2024. PMID: 38773351 Review.
Phenology of five tick species in the central Great Plains.
Ng'eno E, Alkishe A, Romero-Alvarez D, Sundstrom K, Cobos ME, Belgum H, Chitwood A, Grant A, Keck A, Kloxin J, Letterman B, Lineberry M, McClung K, Nippoldt S, Sharum S, Struble S, Thomas B, Ghosh A, Brennan R, Little S, Peterson AT. Ng'eno E, et al. Among authors: brennan r. PLoS One. 2024 May 9;19(5):e0302689. doi: 10.1371/journal.pone.0302689. eCollection 2024. PLoS One. 2024. PMID: 38722854 Free PMC article.
Pavement ant extract is a chemotaxis repellent for C. elegans.
Lopez JS, Ali S, Asher M, Benjamin CA, Brennan RT, Burke MLT, Civantos JM, DeJesus EA, Geller A, Guo MY, Haase Cox SK, Johannsen JM, Kang JSJ, Konsker HB, Liu BC, Oakes KG, Park HI, Perez DR, Sajjadian AM, Torio Salem M, Sato J, Zeng AI, Juarez BH, Gonzalez M, Morales G, Bradon N, Fiocca K, Pamplona Barbosa MM, O'Connell LA. Lopez JS, et al. Among authors: brennan rt. MicroPubl Biol. 2024 Mar 25;2024:10.17912/micropub.biology.001146. doi: 10.17912/micropub.biology.001146. eCollection 2024. MicroPubl Biol. 2024. PMID: 38596360 Free PMC article.
808 results